What percentage of cancers are caused by genetic mutations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What Percentage of Cancers Are Caused by Genetic Mutations?

Approximately 5-10% of all cancers are caused by inherited genetic mutations, while the remaining 90-95% are attributed to environmental and lifestyle factors. 1, 2

The Genetic Contribution to Cancer

Inherited vs. Sporadic Cancer

  • Only 5-10% of cancers arise from inherited germline mutations that are passed from parent to child, conferring significantly increased cancer risk across generations. 1, 2

  • The vast majority (90-95%) of cancers are sporadic, resulting from acquired somatic mutations caused by environmental exposures, lifestyle factors, and aging rather than inherited genetic predisposition. 1, 2

  • Environmental and lifestyle factors that drive the majority of cancers include tobacco use (25-30% of cancer deaths), diet (30-35%), infections (15-20%), and other factors like radiation, obesity, physical inactivity, and environmental pollutants. 2

Specific Cancer Types and Hereditary Contribution

Colorectal Cancer:

  • Between 5-15% of colorectal cancer patients develop disease based on underlying genetic predisposition, often from single-gene mutations. 3
  • The remaining 85-95% are sporadic cases influenced by lifestyle and environmental factors. 3

Breast Cancer:

  • Familial susceptibility accounts for approximately 25% of all breast cancer cases. 4
  • However, BRCA1 and BRCA2 mutations explain only about 15% of familial breast cancers, meaning more than 70% of familial cases remain genetically unexplained. 3, 4
  • In unselected breast cancer patients, BRCA1 mutations occur in <1-7% and BRCA2 in 1-3%. 4

Ovarian Cancer:

  • The likelihood of identifying a BRCA1/2 mutation in women with ovarian cancer at any age is approximately 13-18%. 3

Endometrial Cancer:

  • Approximately 5% of endometrial cancers are due to genetic mutations associated with Lynch syndrome or Cowden syndrome. 3

Male Breast Cancer:

  • 15-20% of male breast cancer cases have a BRCA1/2 mutation, with BRCA2 being particularly strongly associated. 3, 5

High-Penetrance Cancer Susceptibility Genes

The known high-penetrance genes that cause hereditary cancer syndromes collectively account for no more than 25% of familial cancer cases: 3

  • BRCA1 and BRCA2: Hereditary Breast-Ovarian Cancer Syndrome with 50-85% lifetime breast cancer risk 4, 6
  • TP53: Li-Fraumeni Syndrome with 25% breast cancer risk by age 74 and multiple other cancer types 3
  • PTEN: PTEN Hamartoma Tumor Syndrome/Cowden Syndrome with 85% lifetime breast cancer risk 3
  • MLH1, MSH2, MSH6, PMS2: Hereditary Nonpolyposis Colorectal Cancer (Lynch syndrome) 3
  • APC: Familial Adenomatous Polyposis 3
  • CDH1: Hereditary Diffuse Gastric Cancer with 39% lifetime lobular breast cancer risk 3
  • STK11: Peutz-Jeghers Syndrome with 32% breast cancer risk by age 60 3

Clinical Implications

The critical distinction is between germline (inherited) and somatic (acquired) mutations:

  • All cancers are genetic diseases at the cellular level, caused by DNA alterations in cancer cells. 7, 8
  • However, only 5-10% involve inherited germline mutations that can be passed to offspring. 1, 2
  • The remaining 90-95% involve somatic mutations acquired during a person's lifetime from environmental mutagens and lifestyle factors. 1, 2

This has profound implications for cancer prevention:

  • The majority of cancer burden is potentially preventable through lifestyle modifications including smoking cessation, healthy diet, physical activity, maintaining healthy weight, limiting alcohol, and avoiding carcinogen exposure. 1, 2
  • Genetic testing and surveillance are appropriate for the small subset with strong family history or clinical features suggesting hereditary cancer syndromes. 3
  • Even with negative genetic testing, family history of cancer may still indicate increased risk from shared environmental factors or unidentified genetic variants. 4

References

Research

Cancer Prevention and Treatment Based on Lifestyles.

Cancer treatment and research, 2024

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Incidence of Hereditary Breast Cancer with BRCA1 and BRCA2 Gene Mutations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Gene Mutations in Male Breast Cancer

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

BRCA Mutations and Established Cancer Risks

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Genetic analysis of cancer in families.

Cancer surveys, 1990

Research

Facts in cancer genetics.

Patient education and counseling, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.